A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain

Vaccine

Volumn 32, Issue 2, 2014, Pages 230-237

  Opriessnig, Tanja ^a,b   Gerber, Priscilla F ^a,c   Xiao, Chao Ting ^a   Mogler, Mark ^d   Halbur, Patrick G ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Harrisvaccines Inc   (United States)

Author keywords

Experimental model; MPCV2b; PCV2a; Porcine circovirus type 2 (PCV2); Vaccination; Vaccine

Indexed keywords

CIRCUMVENT; IMMUNOGLOBULIN G ANTIBODY; PORCINE CIRCOVIRUS TYPE 2A VACCINE; PORCINE CIRCOVIRUS TYPE 2B VACCINE; SODIUM CHLORIDE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; COLOSTRUM; CONTROLLED STUDY; CROSS PROTECTION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; SEROLOGY; SWINE DISEASE; VACCINATION; VIREMIA; VIRUS STRAIN; WEIGHT GAIN;

EXPERIMENTAL MODEL; MPCV2B; PCV2A; PORCINE CIRCOVIRUS TYPE 2 (PCV2); VACCINATION; VACCINE;

ANIMALS; ANTIBODIES, VIRAL; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; CROSS PROTECTION; PILOT PROJECTS; RANDOM ALLOCATION; SUS SCROFA; SWINE; SWINE DISEASES; VIRAL VACCINES;

EID: 84890554909     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.010     Document Type: Article

References (43)

1. Segalés J., Olvera A., Grau-Roma L., Charreyre C., Nauwynck H., Larsen L., et al. PCV-2 genotype definition and nomenclature. Vet Rec 2008, 162(26):867-868.
2. Dupont K., Nielsen E.O., Baekbo P., Larsen L.E. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Vet Microbiol 2008, 128(1-2):56-64.
3. Patterson A.R., Opriessnig T. Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2). Anim Health Res Rev 2010, 11(2):217-234.
4. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 2007, 19(6):591-615.
5. Opriessnig T., Ramamoorthy S., Madson D.M., Patterson A.R., Pal N., Carman S., et al. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. J Gen Virol 2008, 89(Pt 10):2482-2491.
6. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26(8):1063-1071.
7. Fachinger V., Bischoff R., Jedidia S.B., Saalmüller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26(11):1488-1499.
8. Kixmöller M., Ritzmann M., Eddicks M., Saalmüller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26(27-28):3443-3451.
9. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc 2008, 232(6):906-912.
10. Takahagi Y., Toki S., Nishiyama Y., Morimatsu F., Murakami H. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms. J Vet Med Sci 2010, 72(1):35-41.
11. Martelli P., Ferrari L., Morganti M., De A.E., Bonilauri P., Guazzetti S., et al. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 2011, 149(3-4):339-351.
12. Fraile L., Grau-Roma L., Sarasola P., Sinovas N., Nofrarías M., López-Jimenez R., et al. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 2012, 30(11):1986-1992.
13. Seo H.W., Han K., Oh Y., Park C., Chae C. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological, and immunological examination under field conditions. Vaccine 2012, 30(47):6671-6677.
14. Velasova M., Alarcon P., Werling D., Nevel A., Wieland B. Effectiveness of porcine circovirus type 2 vaccination in reducing the severity of post-weaning multisystemic wasting syndrome in pigs. Vet J. 2013, 197(3):842-847.
15. Xiao C., Halbur P.G., Opriessnig T. Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States. J Virol 2012, 86(22):12469.
16. Guo L.J., Lu Y.H., Wei Y.W., Huang L.P., Liu C.M. Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China. Virol J 2010, 19(7):273.
17. Guo L., Fu Y., Wang Y., Lu Y., Wei Y., Tang Q., et al. A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 2012, 7(7):e41463.
18. Wei C., Zhang M., Chen Y., Xie J., Huang Z., Zhu W., et al. Genetic evolution and phylogenetic analysis of porcine circovirus type 2 infections in southern China from 2011 to 2012. Infect Genet Evol 2013, 1787-1792.
19. Opriessnig T., Xiao C., Gerber P.F., Halbur P.G. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2. Vet Microbiol 2013, 163(1-2):177-183.
20. Vander V.R., Kamrud K., Mogler M., Loynachan A.T., McVicker J., Berglund P., et al. Rapid development of an efficacious swine vaccine for novel H1N1. PLoS Curr 2009, 1RRN1123.
21. Vander Veen R.L., Loynachan A.T., Mogler M.A., Russell B.J., Harris D.L., Kamrud K.I. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine 2012, 30(11):1944-1950.
22. Nawagitgul P., Harms P.A., Morozov I., Thacker B.J., Sorden S.D., Lekcharoensuk C., et al. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin Diagn Lab Immunol 2002, 9(1):33-40.
23. Opriessnig T., Yu S., Gallup J.M., Evans R.B., Fenaux M., Pallarés F.J., et al. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 2003, 40(5):521-529.
24. Opriessnig T., Prickett J.R., Madson D.M., Shen H.G., Juhan N.M., Pogranichniy R.R., et al. Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs. Vet Res 2010, 41(3):31.
25. Gerber P.F., Johnson J., Shen H., Striegel D., Xiao C.T., Halbur P.G., et al. Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs. Res Vet Sci 2013, 95(2):775-781.
26. Gerber P.F., O'Neill K., Owolodun O., Wang C., Harmon K., Zhang J., et al. Comparison of commercial real-time reverse transcription-PCR assays for reliable, early, and rapid detection of heterologous strains of porcine reproductive and respiratory syndrome virus in experimentally infected or noninfected boars by use of different sample types. J Clin Microbiol 2013, 51(2):547-556.
27. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32(6):648-660.
28. Opriessnig T., Thacker E.L., Yu S., Fenaux M., Meng X.J., Halbur P.G. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae, and porcine circovirus type 2. Vet Pathol 2004, 41(6):624-640.
29. Sorden S.D., Harms P.A., Nawagitgul P., Cavanaugh D., Paul P.S. Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. J Vet Diagn Invest 1999, 11(6):528-530.
30. Opriessnig T., O'Neill K., Gerber P.F., de Castro A.M., Gimenez-Lirola L.G., Beach N.M., et al. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Vaccine 2013, 31(3):487-494.
31. Tischer I., Peters D., Rasch R., Pociuli S. Replication of porcine circovirus: induction by glucosamine and cell cycle dependence. Arch Virol 1987, 96(1-2):39-57.
32. Dvorak C.M., Puvanendiran S., Murtaugh M.P. Cellular pathogenesis of porcine circovirus type 2 infection. Virus Res 2013, 174(1-2):60-68.
33. Harms P.A., Halbur P.G., Sorden S.D. Three cases of porcine respiratory disease complex associated with porcine circovirus type 2 infection. J Swine Health Prod 2002, 10(1):27-30.
34. Pallarés F.J., Halbur P.G., Opriessnig T., Sorden S.D., Villar D., Janke B.H., et al. Porcine circovirus type 2 (PCV-2) coinfections in US field cases of postweaning multisystemic wasting syndrome (PMWS). J Vet Diagn Invest 2002, 14(6):515-519.
35. Segalés J., Domingo M., Chianini F., Majó N., Domínguez J., Darwich L., et al. Immunosuppression in postweaning multisystemic wasting syndrome affected pigs. Vet Microbiol 2004, 98(2):151-158.
36. Patterson A.R., Johnson J., Ramamoorthy S., Meng X.J., Halbur P.G., Opriessnig T. Comparison of three enzyme-linked immunosorbent assays to detect porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates. J Vet Diagn Invest 2008, 20(6):744-751.
37. Patterson A.R., Johnson J.K., Ramamoorthy S., Hesse R.A., Murtaugh M.P., Puvanendiran S., et al. Interlaboratory comparison of Porcine circovirus-2 indirect immunofluorescent antibody test and enzyme-linked immunosorbent assay results on experimentally infected pigs. J Vet Diagn Invest 2011, 23(2):206-212.
38. Amory J.R., Mackenzie A.M., Pearce G.P. Factors in the housing environment of finisher pigs associated with the development of gastric ulcers. Vet Rec 2006, 158(8):260-264.
39. Kowalczyk T. Etiologic factors of gastric ulcers in swine. Am J Vet Res 1969, 30(3):393-400.
40. Swaby H., Gregory N.G. A note on the frequency of gastric ulcers detected during post-mortem examination at a pig abattoir. Meat Sci 2012, 90(1):269-271.
41. Guo B., Lager K.M., Henningson J.N., Miller L.C., Schlink S.N., Kappes M.A., et al. Experimental infection of United States swine with a Chinese highly pathogenic strain of porcine reproductive and respiratory syndrome virus. Virology 2013, 435(2):372-384.
42. Sato M., Mikami O., Kobayashi M., Nakajima Y. Apoptosis in the lymphatic organs of piglets inoculated with classical swine fever virus. Vet Microbiol 2000, 75(1):1-9.
43. Ladekjær-Mikkelsen A.-S., Nielsen J., Stadejek T., Storgaard T., Krakowka S., Ellis J., et al. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet Microbiol 2002, 89(2-3):97-114.